Taiwan FDA registration 672991b5d1559e6f7e1dcc0645db9e04
Lizhi pregnancy test reagent series
TW: 立知孕驗孕試劑系列
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd·Registered Nov 16, 2007 – Nov 16, 2012CancelledRegistration details
- Analysis ID
- 672991b5d1559e6f7e1dcc0645db9e04
- Customs Code
- DHY00500257201
Company information
- Manufacturer
- Longteng Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- CHALLENG'S ESSENCE INTERNATIONAL CO., LTD.
Product details
- Intended Use
- Qualitative testing of human pilionic gonadotropins.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1155 Human chorionic gonadotropin testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- Nov 16, 2007
- Expiry Date
- Nov 16, 2012
- Cancellation Date
- May 05, 2014
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Lizhi pregnancy test reagent series in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 672991b5d1559e6f7e1dcc0645db9e04 and manufactured by Longteng Biotechnology Co., Ltd. The authorized representative in Taiwan is CHALLENG'S ESSENCE INTERNATIONAL CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices